Dublin, Ireland-based Covidien agreed to pay $22.50 per share for ev3, a 19 percent premium over the vascular device maker’s Friday closing price.

Covidien Plc <COV.N> plans to acquire ev3 Inc <EVVV.O> for $2.6 billion to boost its business in stents and other vascular devices, underscoring the favorable deal climate in the medical ...

Healthcare products maker Covidien plc ( COV ) said Tuesday that it will buy stents and other vascular devices maker ev3 Inc ( EVVV ) for $2.6.